Sign in
4

Changes in Ownership

LISATA THERAPEUTICS, INC. Filed Acc 0001334549-22-000002

Chief Executive Officer gave up 73,150 shares (to pay taxes)

  • Chief Executive Officer acquired 401,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mazzo David J Chief Executive Officer 2022-01-10 Grant or award +401,000 717,297 D
Mazzo David J Chief Executive Officer 2022-01-10 Shares withheld for taxes −56,410 $0.92 $51,728 660,887 D
Mazzo David J Chief Executive Officer 2022-01-11 Shares withheld for taxes −16,740 $0.87 $14,482 644,147 D
Derivatives
Mazzo David J Chief Executive Officer 2022-01-10 Grant or award · Stock Option (Right to Buy) +200,000 200,000 D
Loading xslF345X03/wf-form4_164202250108559.xml…